JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...

Analyst attributes momentum to worries over prospects of foreign debt repayments and EU review on GSP+ status.

Learn more about whether Lantheus Holdings, Inc. or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Congressional stock trading has been a contentious issue in Washington, with Sen. Jon Ossoff proposing legislation to ban it, ...

We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Inspira Technologies Oxy B.H.N. Ltd.

Lower construction spending on data centers because of DeepSeek could negatively impact heavy equipment stocks like ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

The volatile start to the year has spooked some professional investors but has done little to dowse retail traders’ ...

Retail investors are pushing their weight around in 2025, and buying stocks like Nvidia and Tesla on dips, says Goldman Sachs ...

Haemonetics Corporation’s HAE share price has dipped by 11.58%, which has investors questioning if this is right time to buy.

Legendary short seller Jim Chanos says no one can see the biggest risks facing US markets over the next six to 12 months — ...